» Articles » PMID: 15504952

Molecular Mechanisms of Insulin Resistance That Impact Cardiovascular Biology

Overview
Journal Diabetes
Specialty Endocrinology
Date 2004 Oct 27
PMID 15504952
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin resistance is concomitant with type 2 diabetes, obesity, hypertension, and other features of the metabolic syndrome. Because insulin resistance is associated with cardiovascular disease, both scientists and physicians have taken great interest in this disorder. Insulin resistance is associated with compensatory hyperinsulinemia, but individual contributions of either of these two conditions remain incompletely understood and a subject of intense investigation. One possibility is that in an attempt to overcome the inhibition within the metabolic insulin-signaling pathway, hyperinsulinemia may continue to stimulate the mitogenic insulin-signaling pathway, thus exerting its detrimental influence. Here we discuss some of the effects of insulin resistance and mechanisms of potentially detrimental influence of hyperinsulinemia in the presence of metabolic insulin resistance.

Citing Articles

NOD1: a metabolic modulator.

Tang R, Xie C, Zhang X Front Endocrinol (Lausanne). 2025; 15:1484829.

PMID: 39906040 PMC: 11790428. DOI: 10.3389/fendo.2024.1484829.


[Progress in the Study of Mechanisms Clinically Relevant to Insulin Resistance 
and Lung Cancer].

Chen X, Chen P Zhongguo Fei Ai Za Zhi. 2024; 27(10):755-762.

PMID: 39631832 PMC: 11629090. DOI: 10.3779/j.issn.1009-3419.2024.106.27.


Insulin resistance assessed by estimated glucose disposal rate and risk of atherosclerotic cardiovascular diseases incidence: the multi-ethnic study of atherosclerosis.

Yi J, Qu C, Li X, Gao H Cardiovasc Diabetol. 2024; 23(1):349.

PMID: 39342205 PMC: 11439291. DOI: 10.1186/s12933-024-02437-2.


Acute Hyperglycemia-Induced Injury in Myocardial Infarction.

Pepe M, Addabbo F, Cecere A, Tritto R, Napoli G, Nestola P Int J Mol Sci. 2024; 25(15).

PMID: 39126075 PMC: 11313474. DOI: 10.3390/ijms25158504.


Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma.

Kolokotronis T, Majchrzak-Stiller B, Buchholz M, Mense V, Strotmann J, Peters I Cancers (Basel). 2024; 16(15).

PMID: 39123454 PMC: 11311671. DOI: 10.3390/cancers16152726.